Nonfarm payrolls rose by 143K in January, less than the consensus estimate of +168K and a significant drop from the 307K ...

India’s pharmaceutical industry, valued at around US$58 billion, is projected to reach US$120-130 billion by 2030 and US$400-450 billion by 2047. Growth is driven by rising lifestyle diseases, an ...

India emerges as a promising market with significant growth potential in various sectors due to low product penetration. Factors such as a younger population mix, rising income levels, and changing ...

The first advance estimate of India’s Gross Domestic Product (GDP) in 2024-25, released by the National Statistics Office (NSO) this week, shows a decline in the real GDP growth rate to 6.4% ...

Analysis of Indian economy's growth patterns, fiscal spending, and impact on consumption trends, highlighting need for policy ...

The Nippon India Growth Fund - Growth has an AUM of 35277.81 crores & has delivered CAGR of 25.70% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.58%.

* India has the largest population in the world in the age bracket of 5-24 years with 580 million people, presenting a huge opportunity in the education sector. * India has over 250 million school ...

India must sustain an average growth rate of 8% over the next two decades to realize its ambition of becoming a developed nation by 2047, according to the Economic Survey 2024-25 tabled in Parliament ...

Investopedia / Michela Buttignol The real economic growth rate, or real GDP growth rate, measures economic growth, as expressed by gross domestic product (GDP), from one period to another ...

China said on Friday its population ... growth as the country faces a rapidly ageing population and persistently low birth rates. Once the world’s most populous country, China was overtaken by ...

India's growth momentum has eased materially during 2024, and there are plenty of risks in 2025 and beyond. Real GDP growth should average about 6.5% y-o-y in FY25 and FY26 - below the potential ...